Victor Leung is a partner at Kleiner Perkins Caufield & Byers China.
Before joining KPCB China in 2011, Victor had accrued more than 14 years of private equity and venture investment experience with HSBC Private Equity (Asia) Ltd., as well as five years of investment and commercial banking experience. He set up HSBC Asia Ventures’ China office in 2006 and was the firm’s director and China chief representative. Victor spearheaded HSBC’s venture investment activities in China, and recently he was directly involved in more than 30 investments in Asia. Successful investments include Actions Semiconductor (Nasdaq: ACTS), Canadian Solar Inc. (Nasdaq: CSIQ), China Biodiesel (AIM: CBI.LN), China Flooring Holding (HKSE: 2083.HK) and China Techfaith (Nasdaq: CNTF). Victor was a member of the investment committee of HSBC’s Asian venture fund. He serves as a director on the boards of DeltaChem, Qihang and SinoEv. Earlier in his career, Victor worked in the corporate finance division of ING Barings and was involved in various public offerings and advisory transactions for Asian companies. Previously, he was a relationship manager with HSBC, where he was responsible for the credit relationships with North Asian companies.
Victor was honored as China’s Best Private Equity Investor at the China Most Valuable Venture Enterprises Awards in 2009 and was named among the World Economy Top 10 Outstanding Chinese Investor Leaders by the World Chinese Economy Accreditation Committee in 2009. He is a member of the Association of Chartered Certified Accountants in the United Kingdom and the Hong Kong Institute of Certified Public Accountants. Victor has a bachelor’s degree in economics from the University of Hong Kong, an M.B.A. degree from the London Business School and an M.S. degree in biopharmaceuticals from the University of New South Wales.